Norges Bank Takes $45.28 Million Position in Sotera Health Company $SHC

Norges Bank acquired a new stake in shares of Sotera Health Company (NASDAQ:SHC) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 2,566,807 shares of the company’s stock, valued at approximately $45,278,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of SHC. IFP Advisors Inc increased its holdings in shares of Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after acquiring an additional 1,371 shares in the last quarter. Rothschild Investment LLC acquired a new position in shares of Sotera Health during the fourth quarter valued at about $27,000. True Wealth Design LLC increased its position in shares of Sotera Health by 389.3% during the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after acquiring an additional 1,456 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after acquiring an additional 2,935 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new stake in shares of Sotera Health during the fourth quarter worth about $40,000. Institutional investors own 91.03% of the company’s stock.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 15.36% of the stock is currently owned by insiders.

Sotera Health Stock Up 1.5%

SHC stock opened at $15.86 on Tuesday. The stock’s fifty day simple moving average is $15.41 and its two-hundred day simple moving average is $16.37. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. Sotera Health Company has a 1-year low of $10.80 and a 1-year high of $19.85. The stock has a market cap of $4.52 billion, a P/E ratio of 38.68 and a beta of 1.79.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Analysts expect that Sotera Health Company will post 0.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research report on Friday. They set a “buy” rating and a $20.00 target price for the company. Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Piper Sandler reiterated an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Weiss Ratings downgraded Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Finally, Barclays cut their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.29.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.